Global Recombinant Protein Market

Recombinant Protein Market Size, Share, Growth Analysis, By Product (Cytokines & Growth Factors, Antibodies), By Application (Drug Discovery & Development, Biopharmaceutical Production), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2039 | Region: Global | Published Date: July, 2024
Pages: 165 | Tables: 66 | Figures: 75

Recombinant Protein Market Insights

Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

The global recombinant protein market size is projected to rise at a high CAGR between 2023 and 2030. The genetic level of recombinant proteins proceeds with the isolation of coding sequence for the target protein and its cloning into an expression plasmid vector. The majority of therapeutic recombinant proteins are produced in microbes, yeast, or animal cells in culture. Studying protein-protein interactions requires the use of recombinant proteins. Detergents, beauty products, food supplements, food manufacturing, diagnostics, vaccinations, and therapies are just a few of the applications for these proteins.

Rise in the healthcare organizations investment in research and development activities, growing frequency of chronic illnesses, and a spike in the range of regulatory bodies ought to reduce viral infections are the primary factors towards the growth of the global recombinant protein market.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

There are several dominant players in the recombinant protein business. Several strategic activities, such as mergers, partnerships, alliances, new product launches, acquisitions, and collaborations, are being implemented by the firms to help them increase their international competitiveness. For instance, in February 2021, In order to determine the best antigen dosages for the Phase 3 evaluation of its adjuvanted recombinant protein COVID-19 vaccine candidates, Sanofi and GSK have begun a new Phase 2b trial with 720 individuals who are 18 years old & older. 'Bio-Techne (US) ', 'Thermo Fisher Scientific Inc. (US) ', 'Merck KGaA (Germany) ', 'Danaher Corporation (US) ', 'Abnova Corporation (Taiwan) ', 'BioLegend Inc (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'BPS Bioscience, Inc. (US) ', 'Enzo Biochem Inc. (US) ', 'GenScript (China) ', 'Miltenyi Biotec B.V. & Co. KG (Germany) ', 'Proteintech Group, Inc. (US) ', 'Sino Biological Inc. (China) ', 'ACROBiosystems Group (US) ', 'Aviva Systems Biology Corporation (US) ', 'Sartorius CellGenix GmbH (Germany) ', 'Icosagen (US) ', 'Neuromics (US) ', 'ProSpec-Tany TechnoGene Ltd. (Israel) ', 'ProteoGenix S.A.S (France)'

Over the projected time frame, the antibody segment is projected to expand at an exponential rate. This process has attracted attention in recent years and several businesses have embraced it for use in a variety of applications. After a selection procedure for antibodies with the necessary qualities, the genes can be introduced into an expression system, and the antibodies can be generated in large amounts.

In 2022, North America accounted for the largest share of the global market, and this trend is expected to continue during the forecast. The rising prevalence of chronic diseases, growing R&D investments, increased research and government incentives, and the presence of manufacturing companies in the U.S. are all factors contributing to North America’s market development. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Recombinant Protein Market

Report ID: SQMIG35H2039

$5,300
BUY NOW GET FREE SAMPLE